Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.58 |
| ▸ | PNMT | P11086 | 2/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | IGF1R | P08069 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5934390 | 0.82 | TSHR (0.51) | IDO1TSHRSMN1; SMN2 | |
| SCHEMBL8024771 | 0.81 | AHR (0.61) | IDO1PNMTTAAR1IGF1RALOX15 | |
| SCHEMBL908524 | 0.80 | PNMT (0.61) | IDO1PNMTTAAR1IGF1RALOX15 | |
| SCHEMBL31256667 | 0.80 | CA2 (0.59) | IGF1RALOX15TSHRRECQLHSD17B10 | |
| SCHEMBL507053 | 0.80 | CA2 (0.59) | IGF1RALOX15TSHRRECQLHSD17B10 | |
| SCHEMBL31621229 | 0.80 | RECQL (0.43) | IDO1PNMTTAAR1TSHRRECQL | |
| SCHEMBL2982854 | 0.80 | TTR (0.53) | IGF1RALOX15TSHRRECQLHSD17B10 | |
| SCHEMBL522987 | 0.80 | RECQL (0.43) | IDO1PNMTTAAR1TSHRRECQL | |
| SCHEMBL263603 | 0.78 | NOTUM (0.44) | IDO1PNMTTAAR1IGF1RALOX15 | |
| SCHEMBL1744746 | 0.78 | CYP3A4 (0.68) | IDO1PNMTTAAR1ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 637 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | BASF SE (DE) | 2026-02-24 | — | — | US | claimed |
| CN-117964834-A | Polyacrylate polymers | 巴斯夫欧洲公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116497525-B | Preparation method of heat insulation felt | 安徽弘昌新材料股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116497525-A | Preparation method of heat insulation felt | 安徽弘昌新材料股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116082410-A | Bidentate pyrimidinyl triazole carbene palladium hydrated 3-pyridine sulfonate compound, and preparation method and application thereof | 江苏科技大学 | 2023-05-09 | — | — | CN | claimed |
| EP-3898730-A1 | POLYACRYLATE POLYMER | BASF SE (DE) | 2021-10-27 | — | — | EP | claimed |
| CN-113195564-A | Polyacrylate polymers | 巴斯夫欧洲公司 | 2021-07-30 | — | — | CN | claimed |
| CN-107759763-B | Washing-resistant flame-retardant synergist for textiles and preparation method and application thereof | 北京中纺化工股份有限公司 | 2020-08-04 | — | — | CN | claimed |
| WO-2020127463-A1 | POLYACRYLATE POLYMER | BASF SE (DE) | 2020-06-25 | — | — | WO | claimed |
| CN-107740278-B | Comb-shaped polyurethane flame-retardant water-repellent finishing agent and preparation method and application thereof | 北京中纺化工股份有限公司 | 2019-12-13 | — | — | CN | claimed |
| EP-1546115-A2 | SUBSTITUTED PYRIMIDINES | Merck & Co., Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2004029204-A2 | SUBSTITUTED PYRIMIDINES | MERCK & CO., INC. (US) | 2004-04-08 | — | — | WO | claimed |
| WO-1999052936-A2 | ARGININE PEPTIDE ANALOGS USEFUL AS FIBROBLAST GROWTH FACTOR ANTAGONISTS | EISAI CO., LTD. (JP) | 1999-10-21 | — | — | WO | claimed |
| EP-0237522-B1 | PHARMACEUTICALLY ACTIVE DERIVATIVES OF TRYPTOPHAN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1993-02-24 | — | — | EP | claimed |
| US-5021434-A | Aromatase inhibitors | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | claimed |
| US-4916144-A | ESTROGEN-CAUSE DISEASES | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-04-10 | — | — | US | claimed |
| EP-0254534-A2 | Erythromycin derivatives and compositions and use for inhibiting virus replication and disease | Robinson, William S. (US) | 1988-01-27 | — | — | EP | claimed |
| EP-0196849-A2 | Aminohydroxyalkylbenzene anti-obesity and/or anti-hyperglycaemic agents | BEECHAM GROUP PLC (GB) | 1986-10-08 | — | — | EP | claimed |
| US-4167583-A | A DICHLOROBENZYL ALCOHOL AND PROPYL ALCOHOL; TOPICAL ANTISEPTIC | BAYER AKTIENGESELLSCHAFT (DE) | 1979-09-11 | — | — | US | claimed |
| US-4148625-A | Tetrahydroisophthalimide compounds | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1979-04-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | SAAL1, ATXN2L, VCL | IDO1 2092/4885PNMT 4143/4885TAAR1 1915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.